Skip banner Home   How Do I?   Site Map   Help  
Search Terms: "human cloning"
  FOCUS™    
Edit Search
Document ListExpanded ListKWICFULL format currently displayed   Previous Document Document 5 of 9. Next Document

Locate a Copy of This Publication In Your Library

CIS/Index
Copyright © 2001, Congressional Information Service, Inc.

1 CIS H 36142

TITLE: Human Cloning Prohibition Act of 2001 and the Cloning Prohibition Act of 2001

CIS-NO: 2001-H361-42  
SOURCE: Committee on Energy and Commerce. House  
DOC-TYPE: Hearing Retrieve the full text of testimony  
DATE: June 20, 2001  
LENGTH: iii+110 p.  
CONG-SESS: 107-1  
ITEM-NO: 1019-A-01; 1019-B-01  
SUDOC: Y4.C73/8:107-41  
 
GPO-STOCK-NO: 552-070-27386-7.

SUMMARY:
Committee Serial No. 107-41. Hearing before the Subcom on Health to consider the following bills to prohibit human cloning:
   H.R. 1644, the Human Cloning Prohibition Act of 2001, to prohibit all forms of human cloning and shipping, receiving, or importing a product of human cloning.
   H.R. 2172, the Cloning Prohibition Act of 2001, to amend the Federal Food, Drug, and Cosmetic Act to prohibit the use of human cloning to initiate a pregnancy and the shipment or transportation of a product of human cloning if the product is intended to initiate a pregnancy.

CONTENT-NOTATION: Human cloning prohibition estab

BILLS: 107 H.R. 1644; 107 H.R. 2172

DESCRIPTORS:  
   SUBCOM ON HEALTH, ENERGY AND COMMERCE. HOUSE;  BIOTECHNOLOGY; BIOLOGICAL RESEARCH; GENETICS; MEDICAL ETHICS; MEDICAL REGULATION; HUMAN CLONING PROHIBITION ACT; CLONING PROHIBITION ACT; FEDERAL FOOD, DRUG, AND COSMETIC ACT

01-H361-42 TESTIMONY NO: 1     June 20, 2001 p. 20-44
 
WITNESSES (and witness notations):
   ALLEN, CLAUDE A. (Deputy Secretary, HHS)
 
STATEMENT AND DISCUSSION:
   Opposition to all forms of human cloning, in light of consideration of H.R. 1644 and H.R. 2172.
 
CONTENT NOTATION:
   Human cloning prohibition estab
 
TESTIMONY DESCRIPTORS:
   DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
 
01-H361-42 TESTIMONY NO: 2     June 20, 2001 p. 45-110
 
WITNESSES (and witness notations):
   OKARMA, THOMAS B. (President and CEO, Geron Corp.; also representing Biotechnology Industry Organization)
   KASS, LEON R. (Professor, Committee on Social Thought and the College, University of Chicago)
   GUENIN, LOUIS M. (Lecturer, Ethics in Science, Department of Microbiology and Molecular Genetics, Harvard Medical School)
   NEWMAN, STUART A. (Professor, Cell Biology and Anatomy, New York Medical College)
   PERRY, DANIEL (Executive Director, Alliance for Aging Research)
   NORSIGIAN, JUDY (Executive Director, Boston Women's Health Book Collective)
   DOERFLINGER, RICHARD M. (Associate Director, Policy Development, Secretariat for Pro-Life Activities, National Conference of Catholic Bishops)
   FUKUYAMA, FRANCIS (Professor, Public Policy, George Mason University)
 
STATEMENTS AND DISCUSSION:
   Opposing perspectives on H.R. 1644 and H.R. 2172; differing views on ethical issues involved in consideration of human cloning; importance of cloning involving tissue generation and genetic cell replication in medical research; concerns that legalization of any type of cloning might lead to reproductive cloning; elaboration on issues related to H.R. 1644 and H.R. 2172.
 
CONTENT NOTATION:
   Human cloning prohibition estab
 
TESTIMONY DESCRIPTORS:
   GERON CORP.; BIOTECHNOLOGY INDUSTRY ORGANIZATION; ALLIANCE FOR AGING RESEARCH; BOSTON WOMEN'S HEALTH BOOK COLLECTIVE; NATIONAL CONFERENCE OF CATHOLIC BISHOPS

LOAD-DATE: November 22, 2002




Locate a Copy of This Publication In Your Library

Previous Document Document 5 of 9. Next Document
Terms & Conditions   Privacy   Copyright © 2003 LexisNexis, a division of Reed Elsevier Inc. All Rights Reserved.